1 year return (CAGR)
60.09%
SAB Biotherapeutics Inc Exchange (NASDAQ, USD)
SABS
3.41
-0.01 (-0.29%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-19.96%
5 year return (CAGR)
-49.09%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
310.26M
Price/Sales
-
Ent value
325.42M
Price/Book
1.44
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-45.80%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.45 |
| Daily high | 3.54 |
| Daily low | 3.38 |
| Daily Volume | 712K |
| All-time high | 112.40 |
| 1y analyst estimate | 11.64 |
| Beta | 0.54 |
| EPS (TTM) | -0.16 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| SABS | S&P500 | |
| Current price drop from All-time high | -96.97% | -1.75% |
| Highest price drop | -99.01% | -56.47% |
| Date of highest drop | 7 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -78.89% | -10.69% |
| Avg time to new high | 176 days | 12 days |
| Max time to new high | 1199 days | 1805 days |
News
